Cargando…

Adherence to Long-term Warfarin Therapy Remains Challenging

Detalles Bibliográficos
Autor principal: Ward, Melea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437509/
https://www.ncbi.nlm.nih.gov/pubmed/23627574
http://dx.doi.org/10.18553/jmcp.2013.19.4.290
_version_ 1785092541324984320
author Ward, Melea
author_facet Ward, Melea
author_sort Ward, Melea
collection PubMed
description
format Online
Article
Text
id pubmed-10437509
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104375092023-08-21 Adherence to Long-term Warfarin Therapy Remains Challenging Ward, Melea J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2013-05 /pmc/articles/PMC10437509/ /pubmed/23627574 http://dx.doi.org/10.18553/jmcp.2013.19.4.290 Text en Copyright © 2013, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Letters
Ward, Melea
Adherence to Long-term Warfarin Therapy Remains Challenging
title Adherence to Long-term Warfarin Therapy Remains Challenging
title_full Adherence to Long-term Warfarin Therapy Remains Challenging
title_fullStr Adherence to Long-term Warfarin Therapy Remains Challenging
title_full_unstemmed Adherence to Long-term Warfarin Therapy Remains Challenging
title_short Adherence to Long-term Warfarin Therapy Remains Challenging
title_sort adherence to long-term warfarin therapy remains challenging
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437509/
https://www.ncbi.nlm.nih.gov/pubmed/23627574
http://dx.doi.org/10.18553/jmcp.2013.19.4.290
work_keys_str_mv AT wardmelea adherencetolongtermwarfarintherapyremainschallenging